Month: July 2021

In this article BIIB Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. Biogen upped its revenue guidance for the year, saying it now
0 Comments
In this article SNAP Snap‘s stock rose more than 16% on Thursday after the company reported its second-quarter earnings, beating expectations across the board for earnings, revenue and user growth. Here’s what Snap reported versus Wall Street’s estimates: Adjusted earnings per share: 10 cents vs. 1 cent loss forecast by Refinitiv Revenue: $982 million vs. $846 million
0 Comments
Chinese private educational company New Oriental logo seen in Shanghai. SOPA Images | LightRocket | Getty Images BEIJING — Two U.S.-listed Chinese education stocks plunged more than 40% in pre-market trading Friday after reports of a government crackdown on the sector that included bans on foreign investment. TAL Education shares fell 51% in extended, early-hours
0 Comments
Mike Hambright is a real estate investor, mentor and coach, and is the Founder of FlipNerd.com and the Investor Fuel Mastermind. Take a moment and look back at your first job. For most of us, it was minimum wage or close to minimum wage, and we worked our butts off and were proud of the paycheck we
0 Comments